Li, Mei
Wang, Wenwei
Yang, Yiping
Wang, Yangyang
Funding for this research was provided by:
China Red Cross Foundation Medical Empowerment Public Welfare Special Fund
Article History
Received: 6 March 2025
Accepted: 18 May 2025
First Online: 3 October 2025
Declarations
:
: The study protocol was carried out in compliance with Good Clinical Practice guidelines and the Declaration of Helsinki, and received approval from the Ethics Committee of Taizhou First People's Hospital (Approval No: 2023-KY066-02). Written informed consent was procured from each participant prior to their involvement. Efficacy was assessed by an independent evaluation committee in a blinded manner. Clinical trial number: ChiCTR2500107635.
: The authors declare no competing interests.